07/21/2008 Many Hispanic Diabetics Unaware Of Risk For Eye Disease, Study Finds Many newly diagnosed diabetic Hispanics are unaware that their condition increases their risk for eye disease, according to a study published in the July issue of Archives of Ophthalmology, the Philadelphia Inquirer reports.Hispanics have a diabetes rate that is 1.9 times higher than the rate of whites. more info

07/21/2008 New Air Regulations To Improve Travel By Air For Blind And Partially Sighted In Europe Over the past ten years the European Blind Union has been working to improve travel by air for blind and partially sighted, deaf blind and blind people with additional disabilities. As a result of our work, we are pleased to inform you that from 26 July 2008, the new Air Regulations come into operation at all airports throughout Europe. more info

07/20/2008 New Hope For Adults With 'Lazy Eye' New evidence that the brain regions responsible for vision are capable of adapting in adults offers new hope for those with an untreated condition commonly known as lazy eye. Also called amblyopia, the condition is the most prevalent cause of visual impairment in a single eye, affecting about six million people in the United States alone. more info

07/20/2008 American Optometric Association Applauds Override Of Medicare Cuts The American Optometric Association (AOA) applauds Members of Congress from both parties for voting to override President Bush's veto of legislation passed to stop massive cuts in the Medicare program. Concerned optometrists from across the country have been calling Capitol Hill to urge their representatives in Congress to safeguard patient access to eye and vision care through Medicare. more info

07/19/2008 Recall Of Sandoz Timolol Ophthalmic Solution 0.25% And Sandoz Timolol Ophthalmic Solution 0.5% Due To Potential Health Risk, Canada Health Canada is warning consumers not to use the prescription drug Sandoz Timolol Ophthalmic Solution in 0.25% and 0.5% strengths, because some bottles may contain more of the active ingredient (timolol maleate) than indicated on the label, exposing patients to an increased risk of adverse events. Sandoz Timolol Ophthalmic Solution 0.25% and 0.5% are eye drops taken for treatment of increased intraocular pressure (high fluid pressure inside the eye) and glaucoma. more info